Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

Calvo Martínez, Lourdes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/7866

PMID: 24457911

DOI: 10.1038/bjc.2013.831

ISSN: 0007-0920

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2014

Journal title

BRITISH JOURNAL OF CANCER

Type of content

Artigo